Agenda Topics- Drug discovery technology transfer
- European lead generation and enabling open innovation
- Novel approaches across different therapeutic areas
- Partnering models for academia and industry
- Professional translational research
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Distinguished FacultyTim Hammonds, Deputy Director Drug Discovery, Cancer Research Technology Julian Blagg, Deputy Director, Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research Trevor Howe, Director, Johnson & Johnson Patrick Chaltin, Director, K U Leuven Research & Development Phil Jones, Director, European Screening Centre Newhouse, University of Dundee Garry Pairaudeau, Global Head of Research Outsourcing, AstraZeneca Susanne Muller Knapp, Group Head Structural Genomics Consortium (SGC), University Of Oxford Peter Nussbaumer, Managing Director, Lead Discovery Center GmbH Niclas Nilsson, Open Innovation Manager, LEO Pharma John Spencer, Professor, University of Sussex Mark Moloney, Professor of Chemistry, University of Oxford Kurt Deshayes, Senior Scientist, Early Discovery Biochemistry, Genentech
|